The patient (blood group A RhD positive, Ccee, K−), initially diagnosed with a mixed IgG‐ and IgA‐mediated AIHA in 2019, was admitted to the hospital with an episode of severe relapse (T1) in 2021 (Figure 1A, Table S1). This evidence concerns the gene CD79A and autoimmune hemolytic anemia.